Matches in Nanopublications for { ?s ?p "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP228656.RAY_pR_yku-lhYLPy-q43ZOfrq5g9GXlKzoMu0ro1h1pU130_assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228656.RAY_pR_yku-lhYLPy-q43ZOfrq5g9GXlKzoMu0ro1h1pU130_provenance.
- NP474836.RANSvt4VNJPjGF5H4yyn_eTLjymh1-bKdeb4CUHGqdf8E130_assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474836.RANSvt4VNJPjGF5H4yyn_eTLjymh1-bKdeb4CUHGqdf8E130_provenance.
- NP506361.RAGV5kfm8YZk-TrpIJK8FB8eepeUQqH2EZ5uRSBWBSfYg130_assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506361.RAGV5kfm8YZk-TrpIJK8FB8eepeUQqH2EZ5uRSBWBSfYg130_provenance.
- assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP768441.RAk5cTgHP28Ve4ZrJdFrZPi4KrpEffrdrndlw-weVSZmg130_assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768441.RAk5cTgHP28Ve4ZrJdFrZPi4KrpEffrdrndlw-weVSZmg130_provenance.
- NP912163.RA_ciaUZyyvmJqXA_29NRnq88XUxSrg6-OUIwR0b-PYvg130_assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912163.RA_ciaUZyyvmJqXA_29NRnq88XUxSrg6-OUIwR0b-PYvg130_provenance.
- NP768439.RA4a_SIw_JMugc9hGG8j0bkI3iBCaPLP0otZkQO37dAo4130_assertion description "[In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768439.RA4a_SIw_JMugc9hGG8j0bkI3iBCaPLP0otZkQO37dAo4130_provenance.